Gut microbiota manipulation with prebiotics in patients with non-alcoholic fatty liver disease: a randomized controlled trial protocol

被引：0
|
作者：
Jennifer E. Lambert
Jill A. Parnell
Bertus Eksteen
Maitreyi Raman
Marc R. Bomhof
Kevin P. Rioux
Karen L. Madsen
Raylene A. Reimer
机构：
[1] University of Calgary,Faculty of Kinesiology
[2] Mount Royal University,Health and Physical Education
[3] University of Calgary,Snyder Institute for Chronic Diseases, Health Research and Innovation Center
[4] University of Calgary,Division of Gastroenterology and Hepatology, Department of Medicine
[5] University of Calgary,Department of Microbiology and Infectious Diseases
[6] University of Alberta,Division of Gastroenterology, Centre of Excellence for Gastrointestinal Inflammation and Immunity Research, 7–142 Katz Group–Rexall Centre
[7] Department of Biochemistry & Molecular Biology,undefined
[8] Cumming School of Medicine,undefined
来源：
BMC Gastroenterology | / 15卷
关键词：
Prebiotic fiber; Gut microbiota; Fatty liver; Weight loss; Fibrosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Correction to: Effect of Lycium barbarum polysaccharide supplementation in non-alcoholic fatty liver disease patients: study protocol for a randomized controlled trial
    Lu-Lu Gao
    Yu-Xiang Li
    Jia-Min Ma
    Yi-Qiong Guo
    Lin Li
    Qing-Han Gao
    Yan-Na Fan
    Meng-Wei Zhang
    Xiu-Juan Tao
    Jian-Qiang Yu
    Jian-Jun Yang
    Trials, 22
  • [32] Flaxseed powder supplementation in non-alcoholic fatty liver disease: a randomized controlled clinical trial
    Tian, Yanyan
    Zhou, Yuhao
    Liao, Wang
    Xia, Jiayue
    Hu, Qiaosheng
    Zhao, Qing
    Zhang, Rui
    Sun, Guiju
    Yang, Ligang
    Li, Lihua
    FOOD & FUNCTION, 2025, 16 (04) : 1389 - 1406
  • [33] Characteristics of fecal microbiota in non-alcoholic fatty liver disease patients
    Fan Li
    Gang Sun
    Zikai Wang
    Wenming Wu
    He Guo
    Lihua Peng
    Lili Wu
    Xu Guo
    Yunsheng Yang
    Science China Life Sciences, 2018, 61 : 770 - 778
  • [34] Characteristics of fecal microbiota in non-alcoholic fatty liver disease patients
    Fan Li
    Gang Sun
    Zikai Wang
    Wenming Wu
    He Guo
    Lihua Peng
    Lili Wu
    Xu Guo
    Yunsheng Yang
    Science China(Life Sciences), 2018, (07) : 770 - 778
  • [35] Characteristics of fecal microbiota in non-alcoholic fatty liver disease patients
    Li, Fan
    Sun, Gang
    Wang, Zikai
    Wu, Wenming
    Guo, He
    Peng, Lihua
    Wu, Lili
    Guo, Xu
    Yang, Yunsheng
    SCIENCE CHINA-LIFE SCIENCES, 2018, 61 (07) : 770 - 778
  • [36] The impact of phlebotomy in non-alcoholic fatty liver disease: interim results of a randomized controlled trial
    Adams, Leon
    House, Michael J.
    St Pierre, Timothy G.
    Crawford, Darrell H.
    Stuart, Katherine A.
    Ching, Helena
    Kava, Jenny
    Webb, Malcolm
    Olynyk, John K.
    HEPATOLOGY, 2013, 58 : 498A - 499A
  • [37] SITAGLIPTIN VERSUS PLACEBO IN THE TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE: A RANDOMIZED CONTROLLED TRIAL
    Cui, J. Y.
    Philo, L.
    Nguyen, P.
    Hofflich, H.
    Hernandez, C.
    Bettencourt, R.
    Richards, L.
    Salotti, J.
    Bhatt, A.
    Hooker, J.
    Haufe, W.
    Hooker, C.
    Brenner, D. A.
    Sirlin, C. B.
    Loomba, R.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S192 - S193
  • [38] Curcumin and inflammation in non-alcoholic fatty liver disease: a randomized, placebo controlled clinical trial
    Saadati, Saeede
    Sadeghi, Amir
    Mansour, Asieh
    Yari, Zahra
    Poustchi, Hossein
    Hedayati, Mehdi
    Hatami, Behzad
    Hekmatdoost, Azita
    BMC GASTROENTEROLOGY, 2019, 19 (1)
  • [39] Sitagliptin vs. placebo for non-alcoholic fatty liver disease: A randomized controlled trial
    Cui, Jeffrey
    Philo, Len
    Nguyen, Phirum
    Hofflich, Heather
    Hernandez, Carolyn
    Bettencourt, Ricki
    Richards, Lisa
    Salotti, Joanie
    Bhatt, Archana
    Hooker, Jonathan
    Haufe, William
    Hooker, Catherine
    Brenner, David A.
    Sirlin, Claude B.
    Loomba, Rohit
    JOURNAL OF HEPATOLOGY, 2016, 65 (02) : 369 - 376
  • [40] Curcumin and inflammation in non-alcoholic fatty liver disease: a randomized, placebo controlled clinical trial
    Saeede Saadati
    Amir Sadeghi
    Asieh Mansour
    Zahra Yari
    Hossein Poustchi
    Mehdi Hedayati
    Behzad Hatami
    Azita Hekmatdoost
    BMC Gastroenterology, 19
12345